Connect with us

Technology

AI Transformations in the Epedigree Software Market, Projected USD 4.02 Billion Growth (2024-2028) Driven by Rising Demand for Serializability to Combat Counterfeiting – Technavio Report

Published

on

NEW YORK, Aug. 23, 2024 /PRNewswire/ — The global epedigree software market size is estimated to grow by USD 4.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 18.69% during the forecast period. Rising requirements for serializability to tackle counterfeiting is driving market growth, with a trend towards high-tech developments to smarten pharma supply chain. However, huge time and cost requirements for infrastructural implementation poses a challenge. Key market players include Altair Engineering Inc., ANSYS Inc., Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc., Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Epedigree Software Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 18.69%

Market growth 2024-2028

USD 4023.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

16.01

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 37%

Key countries

US, Germany, Japan, France, and China

Key companies profiled

Altair Engineering Inc., ANSYS Inc., Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc., Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc.

Market Driver

The global pharma industry faces a significant challenge with the proliferation of counterfeit drugs, estimated to be worth billions of dollars. This issue persists due to the intricate pharmaceutical supply chain, which lacks adequate quality control. Forgeries, drug redirection, and other related concerns are on the rise, posing a threat to consumer trust and the industry’s integrity. The pharma industry itself suffers from substantial losses due to the counterfeit market. To address these challenges, ePedigree software has emerged as a crucial solution. Serialization enables stakeholders to take a data-driven approach to inventory network trustworthiness and readiness. Advanced technologies like cloud computing, blockchain, and IoT are expected to revolutionize the pharma supply chain, enhancing efficiency and combating counterfeit drugs. The implementation of real-time product tracking and advanced analytics will streamline business procedures and ensure unit-level tracking. Innovations such as RFID technology, barcode scanners, and tag printers will support the adoption of cutting-edge systems across the pharma production and supply chain network. The expansion of cloud-based network capacities will facilitate extended visibility and collaboration between stakeholders. IoT, in conjunction with analytics, can aid in drug processing from manufacturing to distribution, optimizing stock management and reducing costs. The integration of high-tech developments into the pharma supply chain is fueling the growth of the global ePedigree software market. 

The ePedigree software market is experiencing significant growth due to the increasing demand for drug authentication and supply chain security in the pharmaceutical industry. This software helps ensure the authenticity of pharmaceutical products by tracking and verifying their pedigree throughout the supply chain. With the rise of contaminated medicine and counterfeit drugs, ePedigree software has become essential for hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, and more. Advanced technologies like smart devices, barcodes, cloud computing, and machine learning are driving innovation in the ePedigree software market. Serializability, counterfeiting prevention, and stock management are key features that make ePedigree software an indispensable tool for pharmaceutical businesses. Cloud-based solutions and blockchain technology offer scalability, security, and cost savings, making them popular choices for IT resources in the industry. EPedigree software also offers advanced analytics, big data, virtual assistants, augmented reality (AR), and virtual reality (VR) to enhance supply chain management and improve patient safety. By reducing wastage of products and improving inventory maintenance, ePedigree software helps pharmaceutical businesses save on healthcare expenditures and improve drug safety. Overall, the ePedigree software market is poised for continued growth as it addresses the critical need for advanced technologies in the pharma supply chain. 

Explore a 360° Analysis of the Market: Unveil the Impact of AI. For complete insights- Request Sample!

Market Challenges

The ePedigree software market faces significant challenges due to the high cost and time requirements for implementation. The process begins with analyzing regulatory environments and organizational capabilities, followed by customizing vendor solutions for compliance. These steps increase the total implementation cost, which includes hardware and software systems. Preparing packaging lines for serialization necessitates substantial investments and a lengthy time frame. Transitioning from lot management to unit-level serialization is complex due to the heterogeneous supply chain systems. Customization for diverse regulatory requirements and organizational settings adds to the implementation cost. For instance, in the US and Europe, different regulatory standards exist, requiring unique implementation approaches. In the US, ePedigree is updated when custody changes, while Europe uses a centralized national database. Delayed regulatory deadlines in various regions further hinder market growth due to the intricate adoption process, extended implementation cycle, and the need to integrate ePedigree software with existing infrastructure across organizations and supply chains.The ePedigree software market is experiencing significant growth due to the increasing demand for advanced technologies in the pharmaceutical industry. Challenges such as machine learning for predictive analysis, virtual reality for training, and inventory management for stock control are being addressed through innovative solutions. Wastage of products and storage of drugs are major concerns, leading to the adoption of cloud-based and on-premises solutions, including blockchain technology. Hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, biotechnology firms, medical devices sector, food and beverage, and cosmetics industries are investing heavily in healthcare IT to ensure drug pedigree, serialization, and patient safety. Advanced technologies like machine learning, Internet of Things, and track-and-trace solutions are revolutionizing supply chain management. Scalability and flexibility are crucial factors in choosing between cloud-based and on-premises solutions. Drug safety, hardware, IT resources, and blockchain are key areas of focus for reducing healthcare expenditures and ensuring drug safety.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This epedigree software market report extensively covers market segmentation by

Deployment 1.1 On-premises1.2 CloudEnd-user 2.1 Large enterprise2.2 Small and medium enterprisesGeography 3.1 North America3.2 Europe3.3 APAC3.4 South America3.5 Middle East and Africa

1.1 On-premises- On-premises deployment of ePedigree software refers to installing and managing the software within an organization’s own infrastructure. This approach offers several advantages, including greater control, security, and customization. In regulated industries like pharmaceuticals, data security and regulatory compliance are top priorities. On-premises deployment enables companies to maintain full control over their data and ensure adherence to regulations. Additionally, on-premises deployment allows for greater flexibility in customization and integration with existing systems. While there are upfront investment and maintenance requirements, the control, security, and customization capabilities make on-premises deployment a preferred choice for many organizations in the global ePedigree software market.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The ePedigree software market is experiencing significant growth due to the increasing demand for drug authentication and supply chain security in the pharmaceutical industry. EPedigree software refers to a system that ensures the authenticity, safety, and traceability of pharmaceutical products throughout the supply chain. This software utilizes various advanced technologies such as smart devices, serializability, barcodes, machine learning, Internet of Things, cloud computing, and advanced analytics. The primary goal is to prevent the circulation of contaminated medicine and counterfeit drugs, thereby enhancing patient safety. The market is expected to grow exponentially as the importance of secure and transparent pharmaceutical supply chains continues to increase. Virtual assistants and blockchain technology are also being integrated into ePedigree software to streamline processes and improve efficiency.

Market Research Overview

The ePedigree software market is a rapidly growing segment in the pharmaceutical industry, focused on ensuring the authenticity and safety of pharmaceutical products. This software plays a crucial role in combating the prevalent issues of contaminated medicine and counterfeit drugs by implementing smart devices, serializability, and advanced technologies such as barcodes, cloud computing, and machine learning. The pharma supply chain benefits significantly from ePedigree solutions through improved stock management, inventory maintenance, and wastage reduction. The market encompasses various sectors, including hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, and biotechnology firms in the medical devices sector, food and beverage, and cosmetics industries. EPedigree software solutions offer scalability, flexibility, and cost-effective cloud-based and on-premises options. With the integration of advanced technologies like blockchain, Internet of Things, advanced analytics, big data, virtual assistants, augmented reality (AR), and virtual reality (VR), ePedigree software is revolutionizing healthcare IT investments and enhancing patient safety and drug safety.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

DeploymentOn-premisesCloudEnd-userLarge EnterpriseSmall And Medium EnterprisesGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And Africa

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-transformations-in-the-epedigree-software-market-projected-usd-4-02-billion-growth-2024-2028-driven-by-rising-demand-for-serializability-to-combat-counterfeiting—technavio-report-302229589.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ChipMOS EXPECTS 6.3% FULL YEAR 2024 REVENUE GROWTH, WITH A 5.4% YoY DECEMBER 2024 REVENUE DECLINE AND A 5.7% YoY 4Q24 REVENUE DECLINE

Published

on

By

HSINCHU, Jan. 10, 2025 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services (“OSAT”), today reported its unaudited consolidated revenue for the month of December 2024 and for the fourth quarter ended December 31, 2024. All U.S. dollar figures cited in this press release are based on the exchange rate of NT$32.79 to US$1.00 as of December 31, 2024. This would represent full year 2024 revenue growth of approximately 6.3% compared to the full year 2023.

Revenue for the fourth quarter of 2024 was NT$5,399.6 million or US$164.7 million, representing a decrease of 5.7% from the fourth quarter of 2023, and a decrease of 11.0% from the third quarter of 2024. The Company noted that while the quarterly decline reflects macro industry pricing and demand headwinds, the strong full year 2024 revenue growth reflects continued leadership in its core markets.

Revenue for the month of December 2024 was NT$1,780.1 million or US$54.3 million, representing a decrease of 3.0% from November 2024, and a decrease of 5.4% from December 2023.

Consolidated Monthly Revenues (Unaudited)

December 2024

November 2024

December 2023

MoM Change

YoY Change

Revenues

   (NT$ million)

1,780.1

1,834.6

1,881.5

-3.0 %

-5.4 %

Revenues

   (US$ million)

54.3

55.9

57.4

-3.0 %

-5.4 %

 

Consolidated Quarterly Revenues (Unaudited)

Fourth Quarter

2024

Third Quarter

2024

Fourth Quarter

2023

QoQ Change

YoY Change

Revenues

   (NT$ million)

5,399.6

6,068.0

5,725.4

-11.0 %

-5.7 %

Revenues

   (US$ million)

164.7

185.1

174.6

-11.0 %

-5.7 %

About ChipMOS TECHNOLOGIES INC.:

ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS) (www.chipmos.com) is an industry leading provider of outsourced semiconductor assembly and test services. With advanced facilities in Hsinchu Science Park, Hsinchu Industrial Park and Southern Taiwan Science Park in Taiwan, ChipMOS is known for its track record of excellence and history of innovation. The Company provides end-to-end assembly and test services to leading fabless semiconductor companies, integrated device manufacturers and independent semiconductor foundries serving virtually all end markets worldwide. 

Forward-Looking Statements:

This press release may contain certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes,’ ‘expects,’ ‘anticipates,’ ‘projects,’ ‘intends,’ ‘should,’ ‘seeks,’ ‘estimates,’ ‘future’ or similar expressions or by discussion of, among other things, strategies, goals, plans or intentions. These statements may include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Actual results may differ materially in the future from those reflected in forward-looking statements contained in this document, due to various factors. Further information regarding these risks, uncertainties and other factors are included in the Company’s most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”) and in the Company’s other filings with the SEC.

Contacts:

In Taiwan

Jesse Huang

ChipMOS TECHNOLOGIES INC.

+886-6-5052388 ext. 7715

IR@chipmos.com

In the U.S.

David Pasquale

Global IR Partners

+1-914-337-8801

dpasquale@globalirpartners.com 

View original content:https://www.prnewswire.com/news-releases/chipmos-expects-6-3-full-year-2024-revenue-growth-with-a-5-4-yoy-december-2024-revenue-decline-and-a-5-7-yoy-4q24-revenue-decline-302347705.html

SOURCE ChipMOS TECHNOLOGIES INC.

Continue Reading

Technology

16 Press Releases You Need to See This Week

Published

on

By

Plus, press release highlights from CES 2025.

NEW YORK, Jan. 10, 2025 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

McDonald’s New McValue Platform Is Finally Here
Fans can mix and match with the new Buy One, Add One for $1 offer and fuel up for less with the popular $5 Meal Deal. The brand marks the moment by partnering with John Cena and gifting fans millions of dollars in entertainment, lifestyle promos.ADP National Employment Report: Private Sector Employment Increased by 122,000 Jobs in December; Annual Pay was Up 4.6%
“The labor market downshifted to a more modest pace of growth in the final month of 2024, with a slowdown in both hiring and pay gains,” said Nela Richardson, chief economist, ADP. “Health care stood out in the second half of the year, creating more jobs than any other sector.”Big Lots Closes Sale to Gordon Brothers Retail Partners
Bruce Thorn, Big Lots’ President and Chief Executive Officer, said, “We are pleased to close this strategic transaction, which provides a framework to preserve thousands of jobs, maximize value, and maintain the Big Lots brand.”Globally Renowned Investor and Entrepreneur Kevin O’Leary Joining The People’s Bid for TikTok
The bid aims to purchase TikTok’s U.S. assets and rebuild the platform in a way that prioritizes the privacy of its 170 million American users.NASA to Explore Two Landing Options for Returning Samples from Mars
“Pursuing two potential paths forward will ensure that NASA is able bring these samples back from Mars with significant cost and schedule saving compared to the previous plan,” said NASA Administrator Bill Nelson. “These samples have the potential to change the way we understand Mars, our universe, and – ultimately – ourselves.”Tripadvisor Reveals 2025’s Must-Visit Destinations: Top Picks From Travelers Around the World This year Tripadvisor introduces two new subcategories; Solo Travel Destinations and a special sub-category in celebration of Tripadvisor’s 25th anniversary honoring the Top Destinations of the Last 25 Years based on all time reviews.Ulta Beauty Teams Up with Instacart to Deliver Beauty in a Flash Nationwide
Beauty meets convenience with the largest specialty U.S. beauty retailer now available on Instacart for delivery in as fast as an hour from more than 1,400 stores.Nation’s Top 300 Teen Scientists Selected for Achievements in STEM Innovation and Leadership in Nation’s Oldest and Most Prestigious High School Competition
The 300 scholars will be awarded $2,000 each and their schools will be awarded $2,000 for each enrolled scholar. Scholars were chosen based on their outstanding research, leadership skills, community involvement, commitment to academics, creativity in asking scientific questions and exceptional promise as STEM leaders.$5 Bowls with Five Choices: KFC® Debuts Hot New Lineup of Flavorful Bowls, Including Anticipated Return of Nashville Hot Sauce
Indulge your cravings with a hearty, warm, comforting bowl this winter for just $5 each, making your post-holiday wallet happy. Paramount and Comcast Announce Multi-Year Distribution Agreements
The multi-year deals feature ongoing carriage of Paramount’s networks, including CBS, BET, Comedy Central, MTV, Nickelodeon, Paramount Network and more. Comcast subscribers will also retain access to Paramount’s popular streaming services across Paramount+, Pluto TV and BET+.Michael J. Fox Honored with Presidential Medal of Freedom
President Biden presented Fox with the medal, which honors individuals who have made exemplary contributions to the prosperity, values, or security of the United States, world peace, or other significant societal, public or private endeavors.Hyundai Vehicles Available to “Add to Cart” on Amazon Autos
Car buyers around the U.S. can browse, order and finance any new Hyundai vehicle through a participating Hyundai dealer directly on Amazon Autos, and schedule a pickup from the dealer.The Latest Innovation from CHIPS AHOY! Is…Not A Cookie?! Introducing New CHIPS AHOY! Baked Bites – Bite-Sized Blondies to Satisfy Your Sweet Tooth
Baked into a square shape with a soft and chewy texture inspired by a brownie, CHIPS AHOY! Baked Bites, Blondie variety, are made with delicious, real chocolate chips and no high fructose corn syrup, offering an entirely reimagined CHIPS AHOY! experience. Buffalo thunders back as Zillow’s hottest market for 2025
“Shoppers nationwide should see more options for sale than in recent years, along with slow and steady price growth. That’s the good news. But both buyers and sellers should expect unpredictable mortgage rates,” said Skylar Olsen, Zillow chief economist.Girl Scouts’ 2025 Cookie Season Kicks Off Nationally, Helping Girls Across the Country Unbox Brighter Futures for Themselves
At the close of the 2025 cookie season, two beloved cookie flavors, Girl Scout S’mores® and Toast-Yay!®, will be retired.United Announces Accelerated Timeline for Starlink’s Industry-Leading Connectivity in the Sky
The airline now expects to begin testing Starlink next month with the first commercial flight anticipated to take off this spring on a United Embraer E-175 aircraft. Ultimately, United will add Starlink to its entire fleet.

Read more of the latest releases from PR Newswire.

Do you have a press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

CES 2025

CES took over Las Vegas — and the wire — this week as companies from a range of industries shared news of their latest consumer technology innovations. From advances in mobility and AI to medtech, smart homes and much more, PR Newswire is here to help journalists and consumers keep track of the announcements tied to the consumer electronics tradeshow.

Here are just a few of the big CES press releases sent this week:

What Not to Miss at CES 2025XREAL Announces Groundbreaking Collaborations at CES 2025EcoFlow Debuts AI-Powered OASIS at CES 2025, Maximizing Energy Savings and Extreme Weather PrepSony Exhibits at CES® 2025Exclusive to CES 2025: Bird Buddy Goes Beyond Birds with New Wonder Nature Tech Product Announcement

Catch up on the latest CES 2025 announcements.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they’re signed up, reporters, bloggers, and freelancers have access to the following free features:

Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger’s next story.Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.

About PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at media.relations@cision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/16-press-releases-you-need-to-see-this-week-302347612.html

SOURCE PR Newswire

Continue Reading

Technology

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Published

on

By

RA’ANANA, Israel, Jan. 10, 2025 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (“Inspira” or the “Company”), a leader in life-support technology innovation, announced today that it is preparing for a potential production ramp-up of its INSPIRA™ ART100 device. This strategic readiness comes in light of the recent outbreak of human metapneumovirus (hMPV) in China, which has highlighted the growing need for advanced respiratory care technologies globally.

Inspira is already in discussions with leading providers in affected regions to evaluate demand for advance respiratory solutions and deployment of the INSPIRA™ ART100 device, ensuring rapid response capabilities in case of increased demand.

As global health authorities monitor the hMPV outbreak, Inspira™ believes that it is well-positioned to meet potential increased demand for advanced respiratory support systems. Inspira is working closely with suppliers to secure necessary raw materials and components to meet potential demand spikes. The Company is following the hMPV situation globally and working to adjust production plans as needed.

“While hMPV is not a new virus, and experts indicate the current outbreak is part of normal seasonal patterns, Inspira believes in being prepared,” said Dagi Ben-Noon, CEO of Inspira. “Our increased production capacity will help ensure healthcare providers have access to vital respiratory care equipment should the need arise.”

Inspira emphasizes that its preparedness measures are precautionary and align with the Company’s commitment to global health readiness. The Company will work closely with health authorities in affected regions and adjust its plans based on the evolving situation.

Inspira™ Technologies OXY B.H.N. Ltd.

Inspira Technologies is an innovative medical technology company in the life support and respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA™ ART), a groundbreaking device poised to revolutionize the $19 billion mechanical ventilation market. With 20 million intensive care unit patients with acute respiratory failure each year, many of whom rely on mechanical ventilators, the INSPIRA ART offers a potential alternative by elevating and stabilizing decreasing oxygen saturation levels in minutes without a ventilator, with patients being awake during treatment. The INSPIRA ART is being equipped with a clip-on HYLA™ blood sensor, a real-time continuous blood monitoring technology, aiming to alert physicians of changes in a patient’s condition without the need for intermittent actual blood samples, aiming to support physicians in making informed decisions.

In June and July 2024, respectively, the Company’s INSPIRA™ ART100 system has obtained FDA 510(k) clearance for use in CBP procedures, along with the Israeli AMAR certification for both Extra-Corporeal Membrane Oxygenation and Cardiopulmonary Bypass procedures.

The Company’s other products and technologies, including the INSPIRA ART also known as the INSPIRA™ ART500 or Gen 2, the INSPIRA™ Cardi-ART portable modular device, VORTX™ Oxygen Delivery System, and HYLA™ blood sensor, are currently being designed and developed, and have not yet been tested or used in humans nor approved by any regulatory entity.

For more information, please visit our corporate website at https://inspira-technologies.com

Forward-Looking Statement Disclaimer This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the growing need for advanced respiratory care technologies and its ability to adjust its plans to rapidly respond in case of increased demand. These forward-looking statements and their implications are based solely on the current expectations of the Company’s management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov.

Contact: Inspira Technologies – Media Relations
Email: info@inspirao2.com
Phone: +972-9-9664485

MRK-ARS-113

Copyright © 2018-2025 Inspira Technologies OXY B.H.N. LTD., All rights reserved.

Logo: https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/inspira-preparing-production-in-response-to-spread-of-respiratory-virus-in-china-302347881.html

SOURCE Inspira Technologies

Continue Reading

Trending